U.S. pharma large copyright scrapped two experimental weight loss pills past 12 months—a when-every day pill, lotiglipron, due to elevated liver enzymes in addition to a twice-each day tablet, danuglipron, because of potent Uncomfortable side effects—but CEO Albert Bourla has stated the company is set to “play and earn” from the weight prob